Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Diversified Healthcare Trust (NASDAQ: DHC) closed at $5.01 in the last session, up 1.42% from day before closing price of $4.94. In other words, the price has increased by $1.42 from its previous closing price. On the day, 1.17 million shares were traded. DHC stock price reached its highest trading level at $5.04 during the session, while it also had its lowest trading level at $4.855.
Ratios:
We take a closer look at DHC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 1.62 whereas as Long-Term Debt/Eq ratio is at 1.42.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 15 ’25 when Bilotto Christopher J. bought 20,000 shares for $4.89 per share. The transaction valued at 97,720 led to the insider holds 266,285 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 1213156352 and an Enterprise Value of 3752960256. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.79 while its Price-to-Book (P/B) ratio in mrq is 0.72. Its current Enterprise Value per Revenue stands at 2.44 whereas that against EBITDA is 15.816.
Stock Price History:
The Beta on a monthly basis for DHC is 2.41, which has changed by 1.2352941 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $5.16, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is 9.92%, while the 200-Day Moving Average is calculated to be 37.82%.
Shares Statistics:
According to the various share statistics, DHC traded on average about 833.31K shares per day over the past 3-months and 1272540 shares per day over the past 10 days. A total of 242.15M shares are outstanding, with a floating share count of 217.47M. Insiders hold about 10.19% of the company’s shares, while institutions hold 76.37% stake in the company. Shares short for DHC as of 1764288000 were 5622665 with a Short Ratio of 6.75, compared to 1761868800 on 5493309. Therefore, it implies a Short% of Shares Outstanding of 5622665 and a Short% of Float of 4.5.
Dividends & Splits
The forward annual dividend rate for DHC is 0.04, which was 0.04 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.008097165. The stock’s 5-year Average Dividend Yield is 1.85.
Earnings Estimates
The stock of Diversified Healthcare Trust (DHC) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$1.27 and -$1.28 for the fiscal current year, implying an average EPS of -$1.27. EPS for the following year is -$0.57, with 1 analysts recommending between -$0.57 and -$0.57.
Revenue Estimates
According to 3 analysts,. The current quarter’s revenue is expected to be $392.89M. It ranges from a high estimate of $397.58M to a low estimate of $388.19M. As of. The current estimate, Diversified Healthcare Trust’s year-ago sales were $379.62MFor the next quarter, 3 analysts are estimating revenue of $395.43M. There is a high estimate of $400.4M for the next quarter, whereas the lowest estimate is $390.47M.
A total of 3 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.56B, while the lowest revenue estimate was $1.55B, resulting in an average revenue estimate of $1.55B. In the same quarter a year ago, actual revenue was $1.5BBased on 3 analysts’ estimates, the company’s revenue will be $1.61B in the next fiscal year. The high estimate is $1.63B and the low estimate is $1.59B.
